Journal article · 2004

Lead- and drug-like compounds: the rule-of-five revolution

Christopher A. Lipinski

Drug Discovery Today Technologies, 1(4), 337–341 · Published 1 December 2004 · DOI 10.1016/j.ddtec.2004.11.007

View at the publisherCite this paper

In brief

“Lead- and drug-like compounds: the rule-of-five revolution” is a 2004 journal article by Christopher A. Lipinski, published in Drug Discovery Today Technologies. OpenAlex counts 6,514 citations as of 15 November 2026, which puts it in the top 1% of works published in 2004 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
6,514
Most cited in
2025 (875)
Field-weighted impact
4.60
References
46
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Lipinski, C. A. (2004). Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today Technologies, 1(4), 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007

MLA 9

Lipinski, Christopher A. “Lead- and drug-like compounds: the rule-of-five revolution.” Drug Discovery Today Technologies, vol. 1, no. 4, 2004, pp. 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007.

Chicago

Lipinski, Christopher A. 2004. “Lead- and drug-like compounds: the rule-of-five revolution.” Drug Discovery Today Technologies 1 (4): 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007.

Harvard

Lipinski, C. A. (2004) ‘Lead- and drug-like compounds: the rule-of-five revolution’, Drug Discovery Today Technologies, 1(4), pp. 337–341. doi:10.1016/j.ddtec.2004.11.007.

IEEE

C. A. Lipinski, “Lead- and drug-like compounds: the rule-of-five revolution,” Drug Discovery Today Technologies, vol. 1, no. 4, pp. 337–341, 2004, doi: 10.1016/j.ddtec.2004.11.007.

BibTeX

@article{lipinski2004lead,
  title     = {{Lead- and drug-like compounds: the rule-of-five revolution}},
  author    = {Lipinski, Christopher A.},
  journal   = {Drug Discovery Today Technologies},
  year      = {2004},
  volume    = {1},
  number    = {4},
  pages     = {337--341},
  doi       = {10.1016/j.ddtec.2004.11.007},
  url       = {https://doi.org/10.1016/j.ddtec.2004.11.007}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
2017195195
2018256256
2019297297
2020498498
2021635635
2022724724
2023787787
2024843843
2025875875
2026722722

Its field-weighted citation impact is 4.60: it has been cited 4.60 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • Lipinski's rule of five
  • drug-likeness
  • lead-like compounds
  • physicochemical properties
  • central nervous system drugs
  • chemical tools
  • NIH Roadmap
  • clinical success

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Lipinski, C. A. (2004). Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today Technologies, 1(4), 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007

How many times has this paper been cited?

6,514 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Christopher A. Lipinski.

What is the DOI of this paper?

10.1016/j.ddtec.2004.11.007. The permanent link is https://doi.org/10.1016/j.ddtec.2004.11.007.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.